KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/2017
Total Revenue891.677-
Cost of Revenue594.313-
Gross Profit297.364-
Operating Expenses
Research Development--
Selling General and Administrative16,383.173,307.219
Non Recurring--
Others--
Total Operating Expenses20,266.8534,517.504
Operating Income or Loss-19,375.176-4,517.504
Income from Continuing Operations
Total Other Income/Expenses Net-352.781-17.79
Earnings Before Interest and Taxes-19,375.176-4,517.504
Interest Expense--
Income Before Tax-19,727.957-4,535.294
Income Tax Expense78.58-
Minority Interest--
Net Income From Continuing Ops-19,806.537-4,535.294
Non-recurring Events
Discontinued Operations--
Extraordinary Items--
Effect Of Accounting Changes--
Other Items--
Net Income
Net Income-19,806.537-4,535.294
Preferred Stock And Other Adjustments--
Net Income Applicable To Common Shares-19,806.537-4,535.294